OOI
- 产品代码
- OOI
- 器械名称
- Real Time Nucleic Acid Amplification System
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 862.2570
- FDA 专业组
- Clinical Chemistry
- 上市路径
- 豁免 510(k)(仍须遵守通用控制与注册列名)
- 该代码近三年的 510(k)
- 1 件
- 其中 Summary 已存档
- 1 份,可直接下载
- FDA 历史累计 510(k)
- 14 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
The system is a clinical multiplex instrument intended to measure and sort multiple signals generated my multiple probes, intercalating dyes, or other ligands in an assay from a clinical sample. Signals may be generated by fluorescence or other phenomena and may be measured using filters on a photodiode or other detector. It may integrate sample and/or reagent handling, amplification, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. The system is used with specific assays to comprise an assay test system.
该代码近三年的 510(k)(1 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K243922 | 2025-03-20 | Meridian Bioscience, Inc. | Revogene |
FDA 官方分类页: OOI
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。